Abstract
Endovascular therapy of the femoropopliteal arterial segment has matured substantially over the recent years. The introduction of dedicated wire technology, reentry devices, as well as bare and drug-eluting Nitinol stents has substantially improved technical opportunities and clinical outcomes. Current technological improves are directed at further reductions of restenosis rates in this challenging arterial segment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dotter CT, Judkins MP (1964) Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation 30:654–670
Gruntzig A, Hopff H (1974) Percutaneous recanalization after chronic arterial occlusion with a new dilator-catheter (modification of the Dotter technique) (author’s transl). Dtsch Med Wochenschr 99(49):2502–2510, 2511
Palmaz JC, Sibbitt RR, Reuter SR, Garcia F, Tio FO (1985) Expandable intrahepatic portacaval shunt stents: early experience in the dog. AJR Am J Roentgenol 145(4):821–825
Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12(1):6–12
Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31(1 Pt 2):S1–S296
Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL et al (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116(3):285–292
Zeller T, Saratzis N, Scheinert D, Minar E, Beregi JP, Schillinger M et al (2007) Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE.035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results. J Cardiovasc Surg (Torino) 48(6):719–726
Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J et al (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74(7):1090–1095
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M et al (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3(3):267–276
Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354(18):1879–1888
Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106(12):1505–1509
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16(3):331–338
Dake MD (2011) Zilver PTX: Two-year results confirm benefit of paclitaxel-eluting stent in PAD. International Symposium on Endovascular Therapy (ISET) 2011
Joels CS, York JW, Kalbaugh CA, Cull DL, Langan EM 3rd, Taylor SM (2008) Surgical implications of early failed endovascular intervention of the superficial femoral artery. J Vasc Surg 47(3):562–565
Ryer EJ, Trocciola SM, DeRubertis B, Lam R, Hynecek RL, Karwowski J et al (2006) Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg 20(4):440–446
Hiatt WR (2001) Medical treatment of peripheral arterial disease and claudication. N Engl J Med 344(21):1608–1621
Kalra M, Gloviczki P, Bower TC, Panneton JM, Harmsen WS, Jenkins GD et al (2001) Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg 33(1):6–16
Klevsgard R, Risberg BO, Thomsen MB, Hallberg IR (2001) A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. J Vasc Surg 33(1):114–122
Further Reading
Dake MD (2011) Zilver PTX: Two-year results confirm benefit of paclitaxel-eluting stent in PAD. International Symposium on Endovascular Therapy (ISET) 2011
Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74:1090–1095
Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31:S1–S296
Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Mudde C, Tielemans H, Beregi JP (2005) Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 16:331–338
Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Beregi JP (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106:1505–1509
Krankenberg H, Schluter M, Steinkamp HJ, Burgelin K, Scheinert D, Schulte KL, Minar E, Peeters P, Bosiers M, Tepe G, Reimers B, Mahler F, Tubler T, Zeller T (2007) Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116:285–292
Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, Dave R, Ansel G, Lansky A, Cristea E, Collins TJ, Goldstein J, Jaff MR (2010) Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 3:267–276
Sabeti S, Mlekusch W, Amighi J, Minar E, Schillinger M (2005) Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12:6–12
Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E (2006) Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354:1879–1888
Zeller T, Saratzis N, Scheinert D, Minar E, Beregi JP, Schillinger M, Hausegger HA, Amor M, Quaretti P, Moratto R, Dorange C, Boone E, Krankenberg H (2007) Non-randomized, prospective, multi-centre evaluation of the ABSOLUTE.035 peripheral self-expanding stent system for occluded or stenotic superficial femoral or proximal popliteal arteries (ASSESS Trial): acute and 30-day results. J Cardiovasc Surg (Torino) 48:719–726
The mentioned references are landmark studies in the field of endovascular revascularization and are recommended for further reading.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Baumann, F., Do, DD., Diehm, N. (2013). Endovascular Treatment of Above the Knee and Popliteal Arteries. In: Lanzer, P. (eds) Catheter-Based Cardiovascular Interventions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27676-7_54
Download citation
DOI: https://doi.org/10.1007/978-3-642-27676-7_54
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-27675-0
Online ISBN: 978-3-642-27676-7
eBook Packages: MedicineMedicine (R0)